Literature DB >> 9298172

The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases.

L Aloe1, L Bracci-Laudiero, S Bonini, L Manni.   

Abstract

Numerous studies published in the last 10-15 years have shown that nerve growth factor (NGF), a polypeptide originally discovered in connection with its neurotrophic activity, also acts on cells of the immune system. NGF has been found in various immune organs including the spleen, lymph nodes, and thymus, and cells such as mast cells, eosinophils, and B and T cells. The circulating levels of NGF increase in inflammatory responses, in various autoimmune diseases, in parasitic infections, and in allergic diseases. Stress-related events both in animal models and in man also result in an increase of NGF, suggesting that this molecule is involved in neuroendocrine functions. The rapid release of NGF is part of an alerting signal in response to either psychologically stressful or anxiogenic conditions in response to homeostatic alteration. Thus, the inflammation and stress-induced increase in NGF might alone or in association with other biologic mediators induce the activation of immune cells during immunologic insults. A clearer understanding of the role of NGF in these events may be useful to identify the mechanisms implicated in certain neuroimmune and immune dysfunctions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9298172     DOI: 10.1111/j.1398-9995.1997.tb01247.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  43 in total

1.  Stress, atopy and allergy: A re-evaluation from a psychoneuroimmunologic persepective.

Authors:  Christiane Liezmann; Burghard Klapp; Eva Mj Peters
Journal:  Dermatoendocrinol       Date:  2011-01

Review 2.  Innovative techniques and applications in histochemistry and cell biology.

Authors:  Esther Asan
Journal:  Histochem Cell Biol       Date:  2003-11-28       Impact factor: 4.304

3.  Imbalance of the Nerve Growth Factor and Its Precursor: Implication in Diabetic Retinopathy.

Authors:  Riyaz Mohamed; Azza B El-Remessy
Journal:  J Clin Exp Ophthalmol       Date:  2015-10-25

4.  Nerve growth factor immunoreactivity of mast cells in acute involuted human thymus.

Authors:  Tsvetana Marinova; Stanislav Philipov; Luigi Aloe
Journal:  Inflammation       Date:  2006-12-14       Impact factor: 4.092

5.  Determination of serum interleukin-13 and nerve growth factor in patients with systemic lupus erythematosus and clinical significance.

Authors:  Zusen Xu; Yanlei Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

6.  Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV.

Authors:  E Garaci; M C Caroleo; L Aloe; S Aquaro; M Piacentini; N Costa; A Amendola; A Micera; R Caliò; C F Perno; R Levi-Montalcini
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

7.  Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathway.

Authors:  Fariba Rezaee; Stephanie L Rellick; Giovanni Piedimonte; Stephen M Akers; Heather A O'Leary; Karen Martin; Michael D Craig; Laura F Gibson
Journal:  PLoS One       Date:  2010-03-15       Impact factor: 3.240

8.  Changes in nerve growth factor level and symptom severity following antibiotic treatment for refractory overactive bladder.

Authors:  G Vijaya; R Cartwright; A Derpapas; P Gallo; R Fernando; V Khullar
Journal:  Int Urogynecol J       Date:  2013-02-02       Impact factor: 2.894

9.  Nerve growth factor beta(NGF beta) delivery via a collagen/hydroxyapatite (Col/HAp) composite and its effects on new bone ingrowth.

Authors:  A Letic-Gavrilovic; A Piattelli; K Abe
Journal:  J Mater Sci Mater Med       Date:  2003-02       Impact factor: 3.896

10.  Low frequency of plasma nerve-growth factor detection is associated with death of memory B lymphocytes in HIV-1 infection.

Authors:  K Titanji; A Nilsson; C Mörch; A Samuelsson; A Sönnerborg; S Grutzmeier; M Zazzi; A De Milito
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.